Medicine & Health

New data challenge assumptions, showing Missouri Medicaid recipients are largely employed — often in jobs without benefits, reflecting gaps in wages, coverage and rural access.

WashU will launch a doctoral program in neuroengineering in fall 2027, one of only a few in the United States.

New research from Washington University in St. Louis shows that a mother helps to set the biological clock for her babies while they are still in the womb.

Milan G. Chheda, MD, at WashU Medicine and a brain tumor specialist at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, has received a nearly $1.5 million grant from the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation.

Nearly 70% of Missouri schools tested showed traces of potent synthetic opioids, as a new iHeard poll finds most St. Louis residents are unaware of the threat.

WashU Medicine researchers have developed a software, De-ID, that flags sensitive information in data collected through focus groups, surveys and interviews. It allows for easy removal of such details to enable safe sharing.

New research from WashU Medicine adds to growing evidence that helping brain cells break down and eliminate their own cellular waste is a promising treatment strategy for a variety of neurodegenerative diseases.

The CONNECT program at WashU Medicine streamlines clinical services to provide timely, research-based mental health care that helps teens who have experienced trauma and suicide ideation.

Research in Jon Silva’s lab at WashU McKelvey Engineering highlights the importance of genetic testing for precision medicine.

Developed by WashU Medicine researchers and licensed to WashU startup Wugen, the immunotherapy is designed to treat rare and aggressive types of blood cancer.